Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

The Frequency of Ras Mutations in Cancer

Open access
Prior, Ian A., Hood, Fiona E., Hartley, James L. · 2020 · Cancer Research

Published version of a preprint

Abstract

Ras is frequently mutated in cancer, however, there is a lack of consensus in the literature regarding the cancer mutation frequency of Ras, with quoted values varying from 10%–30%. This variability is at least in part due to the selective aggregation of data from different databases and the dominant influence of particular cancer types and particular Ras isoforms within these datasets. To provide a more definitive figure for Ras mutation frequency in cancer, we cross-referenced the data in all major publicly accessible cancer mutation databases to determine reliable mutation frequency values for each Ras isoform in all major cancer types. These percentages were then applied to current U.S. cancer incidence statistics to estimate the number of new patients each year that have Ras-mutant cancers. We find that approximately 19% of patients with cancer harbor Ras mutations, equivalent to approximately 3.4 million new cases per year worldwide. We discuss the Ras isoform and mutation-specific trends evident within the datasets that are relevant to current Ras-targeted therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-19-3682

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Research works printed but not linked: 1

  1. American Cancer Society, 2018, Cancer Facts & Figures 2018

Cited by

See all 1,130

Metadata

Authors
Prior, I. A., Hood, F. E., & Hartley, J. L.
Affiliations
  • University of Liverpool (GB)
  • Frederick National Laboratory for Cancer Research (US)
Corresponding author
Prior, Ian A.
Venue
Cancer Research
Published
2020-07-15
Volume
80
Issue
14
Pages
2969-2974
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W3013377779
Cited by
1,130
References
57
Citations by year
2026: 185 · 2025: 217 · 2024: 239 · 2023: 188 · 2022: 156 · 2021: 119 · 2020: 24
FWCI
11.82
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • North West Cancer Research Fund (CR1166)
  • National Cancer Institute National Institutes of Health (HHSN261200800001E)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
RAS mutations, mutation frequency, Ras isoforms, cancer incidence, RAS-targeted therapy, oncogenic Ras
MeSH terms
Humans, Mutation, Neoplasms, Signal Transduction, Incidence, ras Proteins, Mutation Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Frequency of Ras Mutations in Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-19-3682
The paper
Prior, I. A., Hood, F. E., & Hartley, J. L. (2020). The Frequency of Ras Mutations in Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-19-3682

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.